ACADIA Pharmaceuticals IncNASDAQ:ACAD
- LAST PRICE18.2700
- TODAY'S CHANGE (%)0.6100 (3.4541%)
- Bid / Lots18.0000/ 1
- Ask / Lots19.0000/ 3
- Open / Previous Close17.9700 / 17.6600
- Day Range
- 52 Week Range
- Volume1,490,474
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACAD |
|---|---|---|
| 09:32 ET | 27988 | 18.03 |
| 09:33 ET | 8693 | 18.2189 |
| 09:35 ET | 6533 | 18.15 |
| 09:37 ET | 11120 | 18.25 |
| 09:39 ET | 6588 | 18.2629 |
| 09:42 ET | 7444 | 18.3191 |
| 09:44 ET | 4135 | 18.17 |
| 09:46 ET | 1028 | 18.21 |
| 09:48 ET | 3548 | 18.19 |
| 09:50 ET | 1889 | 18.215 |
| 09:51 ET | 10808 | 18.075 |
| 09:53 ET | 813 | 18.155 |
| 09:55 ET | 1122 | 18.13 |
| 09:57 ET | 5330 | 18.145 |
| 10:00 ET | 1505 | 18.135 |
| 10:02 ET | 3669 | 18.2 |
| 10:04 ET | 2698 | 18.23 |
| 10:06 ET | 3211 | 18.17 |
| 10:08 ET | 4196 | 18.175 |
| 10:09 ET | 4479 | 18.26 |
| 10:11 ET | 12764 | 18.29 |
| 10:13 ET | 2447 | 18.32 |
| 10:15 ET | 11848 | 18.43 |
| 10:18 ET | 2600 | 18.37 |
| 10:20 ET | 1900 | 18.365 |
| 10:22 ET | 1893 | 18.42 |
| 10:24 ET | 2906 | 18.4 |
| 10:26 ET | 1200 | 18.45 |
| 10:27 ET | 3343 | 18.47 |
| 10:29 ET | 2232 | 18.49 |
| 10:31 ET | 14510 | 18.4483 |
| 10:33 ET | 2415 | 18.48 |
| 10:36 ET | 3243 | 18.5 |
| 10:38 ET | 2482 | 18.49 |
| 10:40 ET | 602 | 18.5 |
| 10:42 ET | 3408 | 18.5 |
| 10:44 ET | 4044 | 18.505 |
| 10:45 ET | 200 | 18.505 |
| 10:47 ET | 3802 | 18.51 |
| 10:49 ET | 3195 | 18.485 |
| 10:51 ET | 900 | 18.47 |
| 10:54 ET | 1882 | 18.53 |
| 10:56 ET | 3702 | 18.59 |
| 10:58 ET | 9338 | 18.61 |
| 11:00 ET | 1300 | 18.61 |
| 11:02 ET | 2900 | 18.61 |
| 11:03 ET | 2100 | 18.66 |
| 11:05 ET | 1450 | 18.67 |
| 11:07 ET | 1438 | 18.71 |
| 11:09 ET | 5261 | 18.685 |
| 11:12 ET | 2010 | 18.66 |
| 11:14 ET | 1109 | 18.65 |
| 11:16 ET | 2450 | 18.64 |
| 11:18 ET | 935 | 18.64 |
| 11:20 ET | 1427 | 18.63 |
| 11:21 ET | 950 | 18.6 |
| 11:23 ET | 1199 | 18.605 |
| 11:25 ET | 2989 | 18.66 |
| 11:27 ET | 3400 | 18.67 |
| 11:30 ET | 2081 | 18.69 |
| 11:32 ET | 1500 | 18.68 |
| 11:34 ET | 15305 | 18.69 |
| 11:36 ET | 3039 | 18.67 |
| 11:38 ET | 7750 | 18.64 |
| 11:39 ET | 938 | 18.655 |
| 11:41 ET | 1600 | 18.64 |
| 11:43 ET | 3402 | 18.64 |
| 11:45 ET | 4572 | 18.62 |
| 11:48 ET | 1401 | 18.6 |
| 11:50 ET | 2577 | 18.6 |
| 11:52 ET | 1014 | 18.57 |
| 11:54 ET | 4004 | 18.56 |
| 11:56 ET | 4898 | 18.555 |
| 11:57 ET | 6274 | 18.51 |
| 11:59 ET | 500 | 18.535 |
| 12:01 ET | 900 | 18.545 |
| 12:03 ET | 1200 | 18.55 |
| 12:06 ET | 2427 | 18.57 |
| 12:08 ET | 2363 | 18.56 |
| 12:10 ET | 1324 | 18.575 |
| 12:12 ET | 2800 | 18.565 |
| 12:14 ET | 4324 | 18.54 |
| 12:15 ET | 1839 | 18.52 |
| 12:17 ET | 5572 | 18.58 |
| 12:19 ET | 2400 | 18.53 |
| 12:21 ET | 1950 | 18.52 |
| 12:24 ET | 1203 | 18.53 |
| 12:26 ET | 3752 | 18.5 |
| 12:28 ET | 5638 | 18.535 |
| 12:30 ET | 1101 | 18.525 |
| 12:32 ET | 2800 | 18.505 |
| 12:33 ET | 1300 | 18.52 |
| 12:35 ET | 900 | 18.54 |
| 12:37 ET | 300 | 18.55 |
| 12:39 ET | 3437 | 18.54 |
| 12:42 ET | 2655 | 18.5 |
| 12:44 ET | 2956 | 18.53 |
| 12:46 ET | 2285 | 18.55 |
| 12:48 ET | 839 | 18.51 |
| 12:50 ET | 5925 | 18.505 |
| 12:51 ET | 9597 | 18.46 |
| 12:53 ET | 1844 | 18.445 |
| 12:55 ET | 1941 | 18.45 |
| 12:57 ET | 526 | 18.45 |
| 01:00 ET | 3000 | 18.45 |
| 01:02 ET | 2641 | 18.44 |
| 01:04 ET | 2100 | 18.38 |
| 01:06 ET | 1552 | 18.37 |
| 01:08 ET | 1704 | 18.35 |
| 01:09 ET | 2363 | 18.345 |
| 01:11 ET | 1800 | 18.34 |
| 01:13 ET | 3752 | 18.31 |
| 01:15 ET | 5078 | 18.32 |
| 01:18 ET | 1885 | 18.325 |
| 01:20 ET | 2500 | 18.34 |
| 01:22 ET | 2774 | 18.335 |
| 01:24 ET | 7261 | 18.25 |
| 01:26 ET | 26753 | 18.3 |
| 01:27 ET | 6112 | 18.34 |
| 01:29 ET | 4378 | 18.36 |
| 01:31 ET | 1367 | 18.43 |
| 01:33 ET | 4429 | 18.4 |
| 01:36 ET | 2641 | 18.39 |
| 01:38 ET | 1067 | 18.41 |
| 01:40 ET | 1524 | 18.44 |
| 01:42 ET | 1036 | 18.435 |
| 01:44 ET | 500 | 18.4 |
| 01:45 ET | 1494 | 18.41 |
| 01:47 ET | 4370 | 18.37 |
| 01:49 ET | 4585 | 18.44 |
| 01:51 ET | 11152 | 18.47 |
| 01:54 ET | 2918 | 18.46 |
| 01:56 ET | 1550 | 18.45 |
| 01:58 ET | 1685 | 18.455 |
| 02:00 ET | 2045 | 18.47 |
| 02:02 ET | 1632 | 18.46 |
| 02:03 ET | 7206 | 18.45 |
| 02:05 ET | 3804 | 18.46 |
| 02:07 ET | 1800 | 18.435 |
| 02:09 ET | 2295 | 18.44 |
| 02:12 ET | 2172 | 18.46 |
| 02:14 ET | 2125 | 18.435 |
| 02:16 ET | 4405 | 18.395 |
| 02:18 ET | 2200 | 18.405 |
| 02:20 ET | 1977 | 18.41 |
| 02:21 ET | 200 | 18.405 |
| 02:23 ET | 4684 | 18.4 |
| 02:25 ET | 13476 | 18.37 |
| 02:27 ET | 6737 | 18.41 |
| 02:30 ET | 1437 | 18.4001 |
| 02:32 ET | 2394 | 18.4 |
| 02:34 ET | 2081 | 18.43 |
| 02:36 ET | 4323 | 18.42 |
| 02:38 ET | 2079 | 18.41 |
| 02:39 ET | 970 | 18.41 |
| 02:41 ET | 11207 | 18.34 |
| 02:43 ET | 5559 | 18.36 |
| 02:45 ET | 3340 | 18.37 |
| 02:48 ET | 2000 | 18.34 |
| 02:50 ET | 2038 | 18.355 |
| 02:52 ET | 739 | 18.365 |
| 02:54 ET | 1579 | 18.34 |
| 02:56 ET | 3100 | 18.315 |
| 02:57 ET | 3685 | 18.32 |
| 02:59 ET | 2000 | 18.31 |
| 03:01 ET | 2810 | 18.305 |
| 03:03 ET | 1517 | 18.27 |
| 03:06 ET | 3707 | 18.3 |
| 03:08 ET | 2300 | 18.32 |
| 03:10 ET | 700 | 18.33 |
| 03:12 ET | 1537 | 18.33 |
| 03:14 ET | 1483 | 18.31 |
| 03:15 ET | 513 | 18.31 |
| 03:17 ET | 2773 | 18.31 |
| 03:19 ET | 1912 | 18.29 |
| 03:21 ET | 2092 | 18.305 |
| 03:24 ET | 4615 | 18.3256 |
| 03:26 ET | 2472 | 18.31 |
| 03:28 ET | 3327 | 18.33 |
| 03:30 ET | 3488 | 18.33 |
| 03:32 ET | 4433 | 18.35 |
| 03:33 ET | 3510 | 18.33 |
| 03:35 ET | 4223 | 18.37 |
| 03:37 ET | 5881 | 18.34 |
| 03:39 ET | 4500 | 18.355 |
| 03:42 ET | 4800 | 18.34 |
| 03:44 ET | 6056 | 18.32 |
| 03:46 ET | 5936 | 18.34 |
| 03:48 ET | 2680 | 18.335 |
| 03:50 ET | 8978 | 18.33 |
| 03:51 ET | 6816 | 18.36 |
| 03:53 ET | 16166 | 18.32 |
| 03:55 ET | 19148 | 18.26 |
| 03:57 ET | 19569 | 18.26 |
| 04:00 ET | 301634 | 18.27 |
Nov 7, 2024
DJ ACADIA Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham, from 8:12AM ET on Thursday Nov 07, 2024 by Dow Jones
8:12AM ET on Thursday Nov 07, 2024 by Dow JonesDJ ACADIA Pharmaceuticals Price Target Maintained With a $27.00/Share by HC Wainwright & Co., from 7:48AM ET on Thursday Nov 07, 2024 by Dow Jones
7:48AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
DJ Acadia Pharmaceuticals to Sell Rare Pediatric Disease Priority Review Voucher, from 5:19PM ET on Tuesday Nov 05, 2024 by Dow Jones
5:19PM ET on Tuesday Nov 05, 2024 by Dow Jones*DJ ACADIA Pharmaceuticals Is Required to Pay Neuren One-Third of the Net Proceeds >ACAD, from 4:07PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:07PM ET on Tuesday Nov 05, 2024 by Dow JonesAcadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.9B | 23.6x | --- |
Azenta Inc | 2.2B | -16.2x | --- |
Catalyst Pharmaceuticals Inc | 2.9B | 20.0x | --- |
Amicus Therapeutics Inc | 3.3B | -30.9x | --- |
Veracyte Inc | 2.8B | -52.2x | --- |
Apellis Pharmaceuticals Inc | 3.7B | -14.5x | --- |
Company Information
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Contact Information
- Headquarters
- 12830 El Camino Real, Suite 400SAN DIEGO, CA, United States 92130
- Phone
- 858-558-2871
- Fax
- 858-558-2872
Executives
- Independent Chairman of the Board
- Stephen Biggar
- Chief Executive Officer, Director
- Catherine Owen Adams
- Chief Financial Officer, Executive Vice President
- Mark Schneyer
- Chief Operating Officer, Executive Vice President, Head of Commercial
- Brendan Teehan
- Executive Vice President, Company Secretary and Chief Legal Officer
- Jennifer Rhodes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $929.2M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.42 |
EPS | $0.78 |
Book Value | $2.62 |
P/E Ratio | 23.6x |
Price/Sales (TTM) | 3.2 |
Price/Cash Flow (TTM) | 20.8x |
Operating Margin | 12.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
